S. Mauen

Proof of principle: quality control of therapeutic cell preparations using senescence-associated DNA-methylation changes

W. Wagner, Anne Schellenberg, Ralph Jans, 2014, BMC Research Notes.

Expression, purification, and structural prediction of the Ets transcription factor ERM.

C. Van Lint, J. Ruysschaert, Y. De Launoit, 2006, Biochimica et biophysica acta.

The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis.

V. Firlej, D. Monté, Y. De Launoit, 2006, Biochimica et biophysica acta.

Proof of principle: quality control of therapeutic cell preparations using senescence-associated DNA-methylation changes

W. Wagner, Anne Schellenberg, Ralph Jans, 2014, BMC Research Notes.

A genetic screen identifies topoisomerase 1 as a regulator of senescence.

D. Bernard, C. Abbadie, Y. De Launoit, 2009, Cancer research.

The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity

D. Monté, J. Baert, C. Beaudoin, 2007, Oncogene.

Expression of the Ets transcription factor Erm is regulated through a conventional PKC signaling pathway in the Molt4 lymphoblastic cell line

C. Van Lint, D. Monté, Y. De Launoit, 2005, FEBS letters.

CYAD-101: An innovative non-gene edited allogeneic CAR-T for solid tumor cancer therapy.

C. Lonez, D. Gilham, E. Cutsem, 2020 .